DarioHealth Expands Platform with New Sleep and Women’s Health Solutions
DarioHealth Corp has released two new programs, Dario Women and Dario Sleep, to address cardiometabolic health through integrated care experiences.
DarioHealth Corp, a healthcare technology company, has recently expanded its provider-backed cardiometabolic platform with the release of two new programs: Dario Women and Dario Sleep.
These programs aim to address drivers of cardiometabolic health through an integrated care experience that combines artificial intelligence (AI)-powered engagement, behavioral support, and access to licensed healthcare providers.
Addressing Obstructive Sleep Apnea and Menopause-Related Sleep Disruptions
Dario Sleep addresses obstructive sleep apnea (OSA), a contributor to cardiometabolic disease and rising healthcare costs. The program enables eligible members to complete a one-night, clinical-grade home sleep test with real-time data transmitted directly to licensed healthcare providers for evaluation.
Based on individual clinical needs, providers determine appropriate treatment pathways, which may include positional therapy, oral appliance therapy, CPAP therapy, or GLP-1 treatment when clinically appropriate.
Supporting Women Navigating Perimenopause and Menopause
Dario Women supports members navigating perimenopause and menopause, life stages frequently associated with sleep disruption, weight changes, metabolic changes, and increased cardiometabolic risk. Eligible members may receive clinical evaluation for hormone replacement therapy when medically appropriate, following a clinical assessment conducted in accordance with evidence-based guidelines.
Integrated Care Experience
Members enrolled in Dario Women and Dario Sleep continue their care journey through Dario’s integrated healthcare platform, which combines connected devices, AI-powered insights, personalized coaching, and provider-backed clinical care.
“Our goal is to connect members with the right care through one coordinated experience,” says Lara Dodo, chief operating officer at Dario.
Rollout to Enterprise Clients
Both programs are expected to roll out to Fortune 500 and other enterprise clients in the fall of 2026.
| Program | Description |
|---|---|
| Dario Sleep | Addresses obstructive sleep apnea through clinical-grade home sleep tests and treatment pathways |
| Dario Women | Supports members navigating perimenopause and menopause with clinical evaluation for hormone replacement therapy |
DarioHealth Corp’s expansion of its platform with Dario Women and Dario Sleep demonstrates the company’s commitment to addressing cardiometabolic health through integrated care experiences.
